Inivos

What Inivos does

Inivos is a UK-headquartered med-tech company that designs, manufactures, and services bio-decontamination and air purification systems for healthcare facilities and life sciences customers. The company is best known for its ProXcide hydrogen peroxide vapour (HPV) systems and Ultra-V UV-C decontamination devices, which together address hospital-acquired infection risks, outbreak management, and rapid room turnover. Its patented Spectrome sensor technology measures accumulated UV-C exposure in real time to validate each decontamination cycle, and the company claims Log-6 Kill (99.9999% pathogen elimination) efficacy with its 7.5% HPV systems. Inivos has built a strong foothold in UK public healthcare, claiming to serve over 50% of NHS Trusts, and has extended its portfolio into air purification via the AIRQON sub-brand (HEPA-800, COMBI-1200, Airial-1000). Operations span the UK, the Netherlands, and Australia.

The company sells capital equipment (ProXcide MAXI and Mini, Ultra-V, Ultra-V Connect, AIRQON units) alongside recurring revenue from consumables (HEPA and activated carbon filters, CapKit, VentKit), annual service-level agreements, and 24/7 on-call rapid response decontamination services. Its go-to-market is enterprise field sales, with 45-minute personalized product demonstrations and an 8-hour on-site response guarantee in the UK, supplemented by a distributor partnership program for international reach. The customer base is concentrated in NHS acute trusts, with additional exposure to private care providers and life sciences/biotech facilities. Inivos holds UKAS-accredited BSI certifications across ISO 9001, ISO 14001, ISO 45001, and ISO 27001, plus Cyber Essentials and CE Marking, providing the compliance foundation required for NHS and EU enterprise procurement.

Name

Inivos

Legal name

Inivos UK Ltd.

Website

https://inivos.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

101–250 employees

Short description

Inivos is a UK-based med-tech company that designs, manufactures, and services hydrogen peroxide vapour (HPV) and UV-C bio-decontamination systems and HEPA/UV air purification units for healthcare facilities and life sciences customers, serving over half of UK NHS Trusts.

Ownership category

akta.pro rank

Product category

Bio-decontamination Equipment

NAICS

Irradiation Apparatus Manufacturing (334517), Industrial and Commercial Fan and Blower and Air Purification Equipment Manufacturing (333413), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841), Industrial & Commercial Fans & Blowers & Air Purifing Equip (3564), Specialty Cleaning, Polishing And Sanitation Preparations (2842)

akta.pro primary industry

Disinfection & Surface Decontamination (Wipes, Sprays, Fogging, UV Robots) (HLAHANAD)

akta.pro secondary industries

Air Quality & Environmental Infection Control (HEPA Filtration, Isolation Barriers, CSSD/HVAC Solutions) (HLAHANAK), Air Quality & Filtration Equipment (IAQ) (IMAHAKAI), Infectious Disease/Pathogen Decontamination (HSAEAHAF)

Keywords

• Bio-decontamination systems
• Infection control equipment
• Hydrogen peroxide vapour
• UV-C disinfection devices
• Medical air purification

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Equipment Sales: Sale of decontamination equipment including ProXcide HPV systems, Ultra-V and Ultra-V Connect UV-C systems, and AIRQON air purification units (HEPA-800, COMBI-1200, AIRIAL-1000). Products available for outright purchase with financing options.
2. On-Call Decontamination Services: Rapid response decontamination services with guaranteed 8-hour on-site response. Services include healthcare facility decontamination, life science contamination control, deep cleaning, duct cleaning, water flushing, and patient equipment decontamination. Available 24/7, 365 days a year.
3. Accessories and Consumables: Replacement filters, pre-filters, and consumables for decontamination equipment including HEPA filters, activated carbon filters, and specialized accessories like CapKit (fire detector caps) and VentKit (ventilation seals).
4. Rental and Service Agreements: Rental packages available for certain air purification models. Service level agreements offered for maintenance including pre-filter cleaning, system cleaning, and filter replacement on routine basis.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

Inivos designs, manufactures and supplies bio-decontamination hardware — ProXcide HPV systems (MAXI and Mini), Ultra-V and Ultra-V Connect UV-C systems, and AIRQON air purification units (Airial-1000, COMBI-1200, HEPA-800) — together with accessories and consumables for healthcare and life science facilities. The company also delivers an 8-hour guaranteed on-call decontamination service and routine contamination control for life sciences, supported by validation reporting and patented Spectrome UV-C sensor technology.

Product overview

Inivos offers a portfolio of automated decontamination products and services for healthcare and life science applications. The core product lines include ProXcide (hydrogen peroxide vapour/HPV systems including MAXI and Mini variants) and Ultra-V (UV-C decontamination systems available in mobile Ultra-V and ceiling-mounted Ultra-V Connect formats). The air purification portfolio includes the Airial-1000 (ceiling-recessed unit), COMBI-1200, and HEPA-800 (mobile HEPA/UV units). Services include an 8-Hour Rapid Response on-call decontamination service for healthcare and routine contamination control for life sciences. Both mobile and fixed solutions are available, and the company provides comprehensive validation and reporting after every decontamination cycle.

Differentiator

Problem solved

Functional benefit

Brands

• AIRQON: Air purification product line featuring HEPA filter and UVGI technologies including HEPA-800, COMBI-1200 mobile units, and AIRIAL-1000 ceiling-mounted unit

Products and services

• ProXcide MAXI Mobile hydrogen peroxide vapour (HPV) decontamination system delivering up to Log-6 Kill (99.9999% pathogen elimination) using vaporised 7.5% hydrogen peroxide, used by healthcare and life science facilities for bio-decontamination of enclosed spaces.
• ProXcide Mini Compact, miniaturised hydrogen peroxide vapour decontamination system for effective decontamination in smaller spaces such as ambulances, isolation rooms and small clinical areas, based on the same HPV technology as ProXcide MAXI.
• Ultra-V Mobile UV-C decontamination system using 10 UV-C bulbs and patented Spectrome sensor technology to monitor and validate each decontamination cycle, delivering automated, no-programming surface disinfection in as little as 3-45 minutes.
• Ultra-V Connect Ceiling-mounted UV-C decontamination system for fixed installation providing continuous environmental decontamination in healthcare settings, with documented efficacy against bacteria, fungi and spores.
• Airial-1000 Ceiling-recessed air purification unit combining HEPA filtration and UV-C germicidal irradiation (UVGI) for continuous 4-way air distribution in rooms up to 100m3, achieving 83.3% reduction in microbial air contaminants over 1 hour.
• COMBI-1200 Mobile air purification unit pairing HEPA H13 filters with UV-C disinfection, removing up to 99.97% of particles down to 0.3 microns and eliminating pathogens from air; achieves 95.4% microbial air contaminant reduction over 1 hour.
• HEPA-800 Mobile HEPA filtration unit with plug-and-play operation, four integrated wheels, built-in temperature and humidity sensors and multiple operating modes; achieves 92.5% microbial air contaminant reduction over 1 hour.
• Accessories and Consumables Replacement filters, pre-filters, activated carbon filters and specialised accessories (including CapKit fire detector caps and VentKit ventilation seals) for Inivos decontamination and air purification equipment.
• 8-Hour Rapid Response Decontamination Service On-call decontamination service for healthcare facilities guaranteeing on-site arrival within 8 hours for emergency bio-decontamination needs, available 24/7/365 in the UK.
• Routine Contamination Control Service Decontamination services for life science facilities, ensuring contamination-free laboratories and preservation of research integrity through flexible decontamination solutions.

Quantifiable outcome

• 98% reduction in total viable count on 160+ high touchpoint surfaces when Ultra-V added to manual cleaning (Royal Wolverhampton NHS Trust)
• +6 more outcomes

Named customers9 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• INNO4COV19 ConsortiumcoreStrategic or Co-development Partner · 1 January 2021European research and innovation consortium focused on COVID-19 solutions. Inivos was awarded funding in the second round (out of 290 applications) for mini VHP decontamination system development. The consortium recognized Inivos hydrogen peroxide technology as best-in-class with efficacy higher than market alternatives.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Halma plc: Halma is a UK-listed conglomerate of safety, health, and environmental technology businesses, several of which serve healthcare and life science infection control. As a UK-based diversified healthcare/safety player, it is a comparable listed reference for Inivos' commercial profile and exit benchmarks.
• STERIS Life Sciences: STERIS is a global incumbent in sterilization and infection prevention, offering VHP and HPV room bio-decontamination plus cleanroom services to life sciences. It overlaps with Inivos on life science contamination control and competes for NHS/biopharma HPV contracts.
• Getinge (Infection Control): Getinge is a broad med-tech incumbent offering disinfection, sterilization, and infection control solutions including HPV systems for healthcare. It competes for NHS framework agreements and life science decontamination tenders against Inivos.
• Clorox Healthcare: Clorox Healthcare is a broad incumbent in healthcare disinfection and surface decontamination products (wipes, sprays, UV-C partnerships). It shapes the broader healthcare disinfection market context for Inivos' HPV/UV-C solutions.

Direct peers

• Tru-D SmartUVC: Tru-D SmartUVC produces UV-C disinfection robots used in healthcare settings, including NHS facilities. It directly competes with Inivos' UV-C systems for terminal room disinfection contracts.
• Xenex Disinfection Services: Xenex pioneered pulsed xenon UV-C robots for hospital room disinfection and is a leading direct competitor to Inivos' Ultra-V UV-C decontamination system, addressing the same HAI reduction use case in acute-care hospitals.
• Bioquell (Ecolab): Bioquell is the original HPV bio-decontamination technology provider for healthcare and life sciences, now part of Ecolab. It is the most direct competitor to Inivos' ProXcide HPV platform, offering room and enclosure decontamination across NHS and biopharma customers.
• TOMI Environmental Solutions (SteraMist): TOMI Environmental Solutions offers ionized hydrogen peroxide (SteraMist) for room and surface decontamination in healthcare and life sciences, providing an alternative HPV-adjacent technology competing with Inivos' ProXcide.

Regional players

• Bio-Rad Laboratories: Bio-Rad supplies laboratory contamination control and analytical instruments to life sciences; while not a direct competitor, it competes for the same cleanroom and contamination control budgets in biotech customers that Inivos serves.

Emerging players

• R-Zero: R-Zero provides UV-C disinfection systems and IAQ monitoring for healthcare and commercial facilities. While primarily US-focused, it represents an emerging, well-funded competitor entering the same UV-C decontamination space as Inivos.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/InivosGroup

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Inivos